Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-028498
Filing Date
2013-05-14
Accepted
2013-05-14 10:50:20
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v344345_10q.htm 10-Q 313461
2 EXHIBIT 31 v344345_ex31.htm EX-31 7414
3 EXHIBIT 32 v344345_ex32.htm EX-32 4819
  Complete submission text file 0001144204-13-028498.txt   2430090

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT iccc-20130331.xml EX-101.INS 214698
5 XBRL TAXONOMY EXTENSION SCHEMA iccc-20130331.xsd EX-101.SCH 31375
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20130331_cal.xml EX-101.CAL 42807
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20130331_def.xml EX-101.DEF 134553
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20130331_lab.xml EX-101.LAB 232659
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20130331_pre.xml EX-101.PRE 173570
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 13839873
SIC: 2835 In Vitro & In Vivo Diagnostic Substances